Research Article
Liquiritin from Radix Glycyrrhizae Protects Cardiac Mitochondria from Hypoxia/Reoxygenation Damage
Figure 2
Experimental design and cell viability assay. (a) HR model and LIQ treatment. ((b)-(c)) The graph indicates H9C2 cell viability under different conditions and treatments. Con: normal control; HR: hypoxia/reoxygenation; LIQ: HR + liquiritin (LIQ); NEC: HR + NecroX-5 (10 μM); LIQ60: HR + LIQ at a dose of 60 μM; vs. Con; vs. HR; vs. LIQ at doses of 1.2, 12, 300, and 600 μM, n = 6 for each group.
(a) |
(b) |
(c) |